• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SIEMENS HEALTHCARE DIAGNOSTICS, INC. ADVIA CENTAUR RUBELLA G; ENZYME LINKED IMMUNOABSORBENT ASSAY, RUBELLA

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SIEMENS HEALTHCARE DIAGNOSTICS, INC. ADVIA CENTAUR RUBELLA G; ENZYME LINKED IMMUNOABSORBENT ASSAY, RUBELLA Back to Search Results
Model Number N/A
Device Problem False Positive Result (1227)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 09/05/2023
Event Type  malfunction  
Manufacturer Narrative
A customer from the united states contacted siemens on 2023-09-05 due to observations of imprecision in calibration and quality control (qc) results for advia centaur rubella g (rub g), lot 246.Specifically, the customer noted imprecision for the level-1 control and repeatedly high cvs for calibration.Siemens service undertook troubleshooting with the customer, including a precision study.Service was sent to the customer site to perform checks and decontamination.Following the service intervention, the customer ran qc with acceptable results before and after successfully recalibrating the assay successfully on 2023-09-19.Patient samples were tested the same day, and one sample was observed to have produced an elevated (positive) rub g result which was discordant relative to alternate-method testing.Siemens was informed of the discordant observation on 2023-09-21.Siemens is investigating.
 
Event Description
The customer reported observation of a positive advia centaur rubella g (rub g) result which was discordant relative to alternate-method testing.The initial elevated result was not reported to the physician.The sample was sent to an external reference lab, and a negative result was returned.This result was accepted as correct.There are no allegations of patient harm, changes in treatment, or delays of diagnosis in association with the observed discordance.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ADVIA CENTAUR RUBELLA G
Type of Device
ENZYME LINKED IMMUNOABSORBENT ASSAY, RUBELLA
Manufacturer (Section D)
SIEMENS HEALTHCARE DIAGNOSTICS, INC.
511 benedict avenue
tarrytown
Manufacturer (Section G)
SIEMENS HEALTHCARE DIAGNOSTICS INC.
333 coney st.
east walpole MA
Manufacturer Contact
barry memishian
333 coney st.
east walpole, MA 
5082985306
MDR Report Key17831088
MDR Text Key324440814
Report Number2432235-2023-00261
Device Sequence Number1
Product Code LFX
UDI-Device Identifier00630414201412
UDI-Public00630414201412
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K003412
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 09/27/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date03/01/2024
Device Model NumberN/A
Device Catalogue Number10310283
Device Lot Number246
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 09/21/2023
Initial Date FDA Received09/28/2023
Date Device Manufactured03/01/2023
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age24 YR
Patient SexFemale
-
-